港股异动 | CRO概念股午后集体拉升美联储加息周期接近结束海外CXO需求有望率先改善

智通财经07-05

智通财经APP获悉，CRO概念股午后集体拉升，截至发稿，泰格医药(03347)涨9.85%，报29.55港元；方达控股(01521)涨6.58%，报0.81港元；康龙化成(03759)涨4.72%，报8.65港元；凯莱英(06821)涨2.47%，报47.65港元；药明生物(02269)涨1.97%，报11.4港元。太平洋证券指出，创新药CXO整体处于行业周期底部，业绩增速有所放缓或者下滑，未来从...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2449823668?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-07-05 14:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2449823668","market":"us","top_or_hot":-1,"title":"港股异动 | CRO概念股午后集体拉升 美联储加息周期接近结束 海外CXO需求有望率先改善","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，CRO概念股午后集体拉升，截至发稿，泰格医药(03347)涨9.85%，报29.55港元；方达控股(01521)涨6.58%，报0.81港元；康龙化成(03759)涨4.72%，报8.65港元；凯莱英(06821)涨2.47%，报47.65港元；药明生物(02269)涨1.97%，报11.4港元。太平洋证券指出，创新药CXO整体处于行业周期底部，业绩增速有所放缓或者下滑，未来从...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1146037.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | CRO概念股午后集体拉升 美联储加息周期接近结束 海外CXO需求有望率先改善</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | CRO概念股午后集体拉升 美联储加息周期接近结束 海外CXO需求有望率先改善\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-05 14:16 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1146037.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，CRO概念股午后集体拉升，截至发稿，泰格医药(03347)涨9.85%，报29.55港元；方达控股(01521)涨6.58%，报0.81港元；康龙化成(03759)涨4.72%，报8.65港元；凯莱英(06821)涨2.47%，报47.65港元；药明生物(02269)涨1.97%，报11.4港元。太平洋证券指出，创新药CXO整体处于行业周期底部，业绩增速有所放缓或者下滑，未来从...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1146037.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IVV","symbol_name":"标普500指数ETF","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1146037.html","article_id":"2449823668","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2449823668","pubTimestamp":1720160207,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"太平洋证券指出，创新药CXO整体处于行业周期底部，业绩增速有所放缓或者下滑，未来从Biotech投融资的恢复到订单的落地以及业绩的改善仍需一定时间；仿制药CXO持续高增长，新签订单保持高增速，未来发展势头良好。未来随着美联储加息周期结束，流动性逐步宽松有望带来投融资回暖，海外需求将先于本土需求改善。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"IVV":"标普500指数ETF","BK4550":"红杉资本持仓","IE00B0JY6N72.USD":"PINEBRIDGE GLOBAL EMERGING MARKETS FOCUS EQUITY \"A\" (USD) ACC","LU0417516738.SGD":"Allianz Hong Kong Equity AT Acc SGD","LU0856984785.SGD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED GROWTH \"ACH\" (SGDHDG) ACC","06821":"凯莱英","OEF":"标普100指数ETF-iShares","LU0348735423.USD":"ALLIANZ HONG KONG EQUITY \"A\" (USD) INC","03759":"康龙化成","BK4559":"巴菲特持仓","HSCEI":"国企指数","BK1141":"生命科学工具和服务","SPY":"标普500ETF","SG9999002562.SGD":"LionGlobal Asia Pacific SGD","01521":"方达控股","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD",".SPX":"S&P 500 Index","OEX":"标普100","LU1720050803.USD":"安联全方位中国股票基金","HSTECH":"恒生科技指数","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","SG9999002463.SGD":"LionGlobal China Growth SGD","UPRO":"三倍做多标普500ETF","BK4534":"瑞士信贷持仓","SPXU":"三倍做空标普500ETF","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","SDS":"两倍做空标普500ETF","SSO":"两倍做多标普500ETF","LU0823426308.USD":"法巴中国股票基金","BK1589":"北水核心资产","LU1688375341.USD":"贝莱德中国灵活股票基金","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","LU2039709279.SGD":"MANULIFE GF DRAGON GROWTH \"AA\" (SGDHDG) INC","LU0979878070.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"A\" (USD) ACC","LU0051755006.USD":"摩根大通中国A (dist)","LU0181495838.USD":"施罗德新兴亚洲A Acc","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","02269":"药明生物","SH":"标普500反向ETF","LU0823426480.USD":"法巴中国股票经典Dis","LU0052750758.USD":"富兰克林中国基金A Acc","LU0043850808.USD":"HSBC GIF ASIA EX JAPAN EQUITY \"AD\" INC","CXO":"康休","03347":"泰格医药","LU0359201612.USD":"贝莱德中国基金A2","07226":"XL二南方恒科","LU0516422440.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"A\" (USD) ACC","YANG":"三倍做空富时中国ETF-Direxion","BK1521":"挪威政府全球养老基金持仓"},"translate_title":"Changes in Hong Kong stocks, CRO concept stocks collectively rose in the afternoon, the Federal Reserve's rate hike cycle is nearing the end, and overseas CXO demand is expected to be the first to improve","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"YANG":1,"SPY":1,"HSTECH":1,"HSCEI":1,"CXO":1,"07226":1,"01521":0.9,"02269":0.9,"06821":0.9,"03759":0.9,"03347":0.9,"OEF":0.6,"OEX":0.6,"SDS":0.6,"SH":0.6,"SPXU":0.6,"SSO":0.6,"UPRO":0.6,".SPX":0.6,"ESmain":0.6,"IVV":0.6},"content_text":"智通财经APP获悉，CRO概念股午后集体拉升，截至发稿，泰格医药(03347)涨9.85%，报29.55港元；方达控股(01521)涨6.58%，报0.81港元；康龙化成(03759)涨4.72%，报8.65港元；凯莱英(06821)涨2.47%，报47.65港元；药明生物(02269)涨1.97%，报11.4港元。太平洋证券指出，创新药CXO整体处于行业周期底部，业绩增速有所放缓或者下滑，未来从Biotech投融资的恢复到订单的落地以及业绩的改善仍需一定时间；仿制药CXO持续高增长，新签订单保持高增速，未来发展势头良好。未来随着美联储加息周期结束，流动性逐步宽松有望带来投融资回暖，海外需求将先于本土需求改善。行业层面建议关注：美联储利率政策变化、投融资的边际变化、海外需求的逐步复苏、地缘政治、潜在国内创新药全产业链支持政策的出台。信达证券认为，离岸外包合同金额的持续增长进一步验证了全球订单转移趋势，虽然欧美CXO占据全球主要市场，但由于人力成本、环保压力、产能配置等原因，全球产能持续向中国、印度等国转移；预计工程师红利带来的成本优势将持续较长时间。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2449823668"}

港股异动 | CRO概念股午后集体拉升 美联储加息周期接近结束 海外CXO需求有望率先改善

精彩评论

港股异动 | CRO概念股午后集体拉升美联储加息周期接近结束海外CXO需求有望率先改善